MILLER THOMAS B
Insider CIK 1236896 · XXIA Chief Financial Officer · EYES Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2018-01-19 | 2018-01-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | P Buy deriv | 2017-05-22 | 2017-05-23 | 5,200 | $0.36 | $1.9K | 75,635 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | P Buy deriv | 2017-05-22 | 2017-05-23 | 5,000 | $0.37 | $1.9K | 80,635 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | P Buy deriv | 2017-05-22 | 2017-05-23 | 5,500 | $0.37 | $2.0K | 86,135 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | P Buy deriv | 2017-05-19 | 2017-05-23 | 3,000 | $0.35 | $1.1K | 70,435 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2017-03-14 | 2017-03-16 | 67,435 | — | $0 | 67,435 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award | 2017-03-14 | 2017-03-16 | 67,435 | $1.47 | $99.1K | 78,354 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2017-01-03 | 2017-01-05 | 181,980 | — | $0 | 181,980 | SEC↗ |
| EYES SECOND SIGHT MEDICAL PRODU | A Award deriv | 2016-01-21 | 2016-01-25 | 38,225 | — | $0 | 38,225 | SEC↗ |
| XXIA IXIA | S Sale | 2013-08-16 | 2013-08-20 | 264 | $15.54 | $4.1K | 115,482 | SEC↗ |
| XXIA IXIA | S Sale | 2013-08-16 | 2013-08-20 | 162 | $15.54 | $2.5K | 115,320 | SEC↗ |
| XXIA IXIA | S Sale | 2013-08-16 | 2013-08-20 | 61 | $15.54 | $948 | 115,259 | SEC↗ |
| XXIA IXIA | S Sale | 2013-08-16 | 2013-08-20 | 221 | $15.54 | $3.4K | 115,746 | SEC↗ |
| XXIA IXIA | A Award deriv | 2013-04-12 | 2013-04-16 | 51,000 | — | $0 | 51,000 | SEC↗ |
| XXIA IXIA | S Sale | 2013-03-05 | 2013-03-06 | 14,345 | $21.15 | $303.4K | 121,533 | SEC↗ |
| XXIA IXIA | S Sale | 2013-03-04 | 2013-03-06 | 810 | $20.78 | $16.8K | 135,878 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-25 | 2013-02-27 | 1,127 | $20.40 | $23.0K | 138,221 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-25 | 2013-02-27 | 1,533 | $20.37 | $31.2K | 136,688 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-19 | 2013-02-20 | 161 | $20.90 | $3.4K | 139,832 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-19 | 2013-02-20 | 357 | $20.99 | $7.5K | 141,243 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-19 | 2013-02-20 | 264 | $20.90 | $5.5K | 139,348 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-19 | 2013-02-20 | 220 | $20.90 | $4.6K | 139,612 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-19 | 2013-02-20 | 1,250 | $20.95 | $26.2K | 139,993 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-15 | 2013-02-20 | 500 | $21.29 | $10.6K | 141,600 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-04-12 | 500 | $20.60 | $10.3K | 136,350 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-04-12 | 1,000 | $20.62 | $20.6K | 136,850 | SEC↗ |
| XXIA IXIA | M Exercise | 2013-02-11 | 2013-04-12 | 2,450 | $8.88 | $21.8K | 137,850 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-04-12 | 950 | $20.67 | $19.6K | 135,400 | SEC↗ |
| XXIA IXIA | M Exercise deriv | 2013-02-11 | 2013-02-11 | 2,450 | — | $0 | 50,826 | SEC↗ |
| XXIA IXIA | M Exercise | 2013-02-11 | 2013-02-11 | 2,450 | $8.88 | $21.8K | 144,550 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-02-11 | 950 | $20.67 | $19.6K | 142,100 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-02-11 | 500 | $20.60 | $10.3K | 143,050 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-11 | 2013-02-11 | 1,000 | $20.62 | $20.6K | 143,550 | SEC↗ |
| XXIA IXIA | M Exercise | 2013-02-08 | 2013-04-12 | 11,724 | $8.88 | $104.1K | 147,124 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-04-12 | 2,000 | $20.20 | $40.4K | 145,124 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-04-12 | 1,000 | $20.36 | $20.4K | 144,124 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-04-12 | 2,000 | $20.38 | $40.8K | 142,124 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-04-12 | 2,000 | $20.50 | $41.0K | 140,124 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-04-12 | 4,724 | $20.55 | $97.1K | 135,400 | SEC↗ |
| XXIA IXIA | M Exercise deriv | 2013-02-08 | 2013-02-11 | 11,724 | — | $0 | 53,276 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-02-11 | 4,724 | $20.55 | $97.1K | 142,100 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-02-11 | 2,000 | $20.50 | $41.0K | 146,824 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-02-11 | 2,000 | $20.38 | $40.8K | 148,824 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-02-11 | 1,000 | $20.36 | $20.4K | 150,824 | SEC↗ |
| XXIA IXIA | S Sale | 2013-02-08 | 2013-02-11 | 2,000 | $20.20 | $40.4K | 151,824 | SEC↗ |
| XXIA IXIA | M Exercise | 2013-02-08 | 2013-02-11 | 11,724 | $8.88 | $104.1K | 153,824 | SEC↗ |
| XXIA IXIA | A Award deriv | 2013-02-07 | 2013-04-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XXIA IXIA | A Award | 2013-02-07 | 2013-04-12 | 2,500 | — | $0 | 135,400 | SEC↗ |
| XXIA IXIA | A Award deriv | 2013-02-07 | 2013-02-11 | 27,500 | — | $0 | 27,500 | SEC↗ |
| XXIA IXIA | A Award | 2013-02-07 | 2013-02-11 | 9,200 | — | $0 | 142,100 | SEC↗ |
| XXIA IXIA | A Award deriv | 2012-12-13 | 2012-12-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XXIA IXIA | A Award | 2012-12-13 | 2012-12-17 | 6,700 | — | $0 | 132,900 | SEC↗ |
| XXIA IXIA | S Sale | 2012-11-16 | 2012-11-20 | 259 | $13.49 | $3.5K | 126,200 | SEC↗ |
| XXIA IXIA | S Sale | 2012-11-16 | 2012-11-20 | 217 | $13.49 | $2.9K | 126,459 | SEC↗ |
| XXIA IXIA | S Sale | 2012-08-16 | 2012-08-20 | 687 | $14.99 | $10.3K | 125,542 | SEC↗ |
| XXIA IXIA | S Sale | 2012-08-16 | 2012-08-20 | 575 | $14.99 | $8.6K | 126,229 | SEC↗ |
| XXIA IXIA | A Award deriv | 2012-03-16 | 2012-03-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XXIA IXIA | S Sale | 2012-02-16 | 2012-02-21 | 246 | $14.19 | $3.5K | 125,670 | SEC↗ |
| XXIA IXIA | A Award deriv | 2012-02-02 | 2012-02-06 | 33,000 | — | $0 | 33,000 | SEC↗ |
| XXIA IXIA | A Award | 2012-02-02 | 2012-02-06 | 11,000 | — | $0 | 125,916 | SEC↗ |